Akshay Vaishnaw, President, R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 5,720 shares at $191.45 ($1.1M) on 2021-12-23, disclosed to the SEC on 2021-12-23.
Seasonal sale ($1.1M) by President, R&D — this insider has traded ALNY in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.48 | 122 | $23K | 2.1% |
| 2 | $189.13 | 2,415 | $457K | 42.0% |
| 3 | $190.50 | 1 | $191 | 0.0% |
| 4 | $186.22 | 124 | $23K | 2.1% |
| 5 | $187.08 | 137 | $26K | 2.4% |
| 6 | $187.35 | 130 |
| $24K |
| 2.2% |
| 7 | $188.26 | 127 | $24K | 2.2% |
| 8 | $189.01 | 73 | $14K | 1.3% |
| 9 | $189.18 | 8 | $2K | 0.1% |
| 10 | $189.24 | 144 | $27K | 2.5% |
| 11 | $190.02 | 144 | $27K | 2.5% |
| 12 | $190.27 | 5 | $951 | 0.1% |
| 13 | $190.33 | 73 | $14K | 1.3% |
| 14 | $190.39 | 142 | $27K | 2.5% |
| 15 | $190.86 | 125 | $24K | 2.2% |
| 16 | $191.45 | 1,000 | $191K | 17.6% |
| 17 | $192.25 | 73 | $14K | 1.3% |
| 18 | $193.37 | 126 | $24K | 2.2% |
| 19 | $193.67 | 145 | $28K | 2.6% |
| 20 | $195.11 | 303 | $59K | 5.4% |
| 21 | $195.11 | 303 | $59K | 5.4% |
| Total | $190.30 avg | 5,720 | $1.1M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |